Your new post is loading...
Reports published in 2016 on the Corporate Reputation of Pharma, as viewed by over 1,000 patient groups
The corporate Reputation of Pharma is growing:
In 2011 there was 42.0% of patient groups stating that the corporate reputation of the Pharma industry is "excellent" or "good". Although this percentage decreased to a 34% in 2012, it has increased ever since to 44.7% in 2015!
For a quick summary about our methodology and series of reports on corporate reputation of pharma and medical devices view the powerpoint here
Of course, this global indicators must be seen from the differentiated perspectives of regions and diseases!
Reports of Pharma's Corporate Reputation over regions:
GLOBAL, EUROPE and EASTERN Europe; GERMANY, ITALY, NORDIC, LATIN AMERICA, SPAIN, UK & USA
Reports of Pharma's Corporate Reputation over therapeutic areas.:
Cancer; Circulatory conditions; Diabetes; HIV/Aids; Hepatitis; Neurological conditions; Mental health; Skin; Respiratory and Rare diseases.
Reports for Respiratory and Circulatory conditions are forthcoming.
Via rob halkes
Great to seen how pharma's Corporate Reputation in the eyes of the patients is growing globally from 2011 to 2015, with a dip in 2012. Study the nuances for different global regions and Disease conditions!